Gene expression analysis revealed downregulation of complement receptor 1 in clonal B cells in cold agglutinin disease
December 22, 2023
SAR445088 Shows Sustained Complement Inhibition in CAD
December 9, 2023
12 Mistakes You Make at the Doctor’s Office. A physician’s advice for how to make your visit go well
December 8, 2023
Delayed cold-type autoimmune hemolytic anemia responding to Rituximab in a melanoma patient treated with Ipilimumab and Nivolumab.
November 2023
Having One Autoimmune Condition Can Increase Your Chance of Developing Others—Here’s Why
November 19 2023
Cytokine polymorphisms in patients with autoimmune hemolytic anemia
November 9, 2023
Total arch replacement for an aortic arch aneurysm with cold agglutinin disease after rituximab and plasmapheresis.
October 10, 2023
Sutimlimab suppresses SARS-CoV-2 mRNA vaccine-induced hemolytic crisis in a patient with cold agglutinin disease
2023
Cold agglutinin disease: A case report with atypical clinical findings.
August 22, 2023
Associated Transient Ischemic Attack, Non-ST Elevation Myocardial Infarction, and Skin Necrosis: A Case Report.
August 1, 2023
Continuing To Increase – Autoimmune Diseases Now Affect Over 10% of the Population
July 24, 2023
Bortezomib and daratumumab in refractory autoimmune hemolytic anemia
July 7, 2023
Explore a CXCL4-mediated mechanism by which TLRs cause autoimmunity in human B cells, breaching bone marrow tolerance.
September 29 2023
Understanding the Burden of Cold Agglutinin Disease
April 4, 2023
Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease
May 10, 2023
Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease
May 10, 2023
Welcome to ‘Exploring the Jungle,’ a trek into the unknowns of CAD
May 8 2023
Sutimlimab for the Treatment of Cold Agglutinin Disease
May 2023
Sutimlimab for the Treatment of Cold Agglutinin Disease
May 2023
FDA approves expanded label of Enjaymo® (sutimlimab-jome) to include long-term safety and efficacy for people with cold agglutinin disease
January 2023
Welcome to CADdy News Our 3nd edition newsletter
Welcome to CADdy News Our 2nd edition newsletter
Welcome to CADdy News Our 1st edition newsletter
Copyright © 2025 Cold Agglutinin Disease Foundation - All Rights Reserved.